Author:
Yamamoto Motohisa,Takahashi Hiroki,Takano Kenichi,Shimizu Yui,Sakurai Nodoka,Suzuki Chisako,Naishiro Yasuyoshi,Yajima Hidetaka,Awakawa Teruhito,Himi Tetsuo,Nakase Hiroshi
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology
Reference7 articles.
1. Rituximab for IgG4-related disease: a prospective, open-label trial;Carruthers;Ann Rheum Dis,2015
2. Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years;Yamamoto;Ann Rheum Dis,2015
3. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011;Umehara;Mod Rheumatol,2012
4. Efficacy and safety of rituximab treatment in early primary Sjogren's syndrome: a prospective, multi-center, follow-up study;Carubbi;Arthritis Res Ther,2013
5. Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjogren's syndrome: a pilot study;Adler;Arthritis Care Res (Hoboken),2013
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献